Regulation and metabolic functions of mTORC1 and mTORC2
Cells metabolize nutrients for biosynthetic and bioenergetic needs to fuel growth and
proliferation. The uptake of nutrients from the environment and their intracellular metabolism …
proliferation. The uptake of nutrients from the environment and their intracellular metabolism …
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Ribosome biogenesis and protein synthesis are fundamental rate-limiting steps for cell
growth and proliferation. The ribosomal proteins (RPs), comprising the structural parts of the …
growth and proliferation. The ribosomal proteins (RPs), comprising the structural parts of the …
Integrated proteogenomic characterization of clear cell renal cell carcinoma
To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma
(ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic …
(ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic …
Ribosome biogenesis in cancer: new players and therapeutic avenues
J Pelletier, G Thomas, S Volarević - Nature Reviews Cancer, 2018 - nature.com
The ribosome is a complex molecular machine composed of numerous distinct proteins and
nucleic acids and is responsible for protein synthesis in every living cell. Ribosome …
nucleic acids and is responsible for protein synthesis in every living cell. Ribosome …
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis
Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only a
small subset of these cells generates metastases. We conducted an in vivo genome-wide …
small subset of these cells generates metastases. We conducted an in vivo genome-wide …
Targeting mTOR and metabolism in cancer: lessons and innovations
Cancer cells support their growth and proliferation by reprogramming their metabolism in
order to gain access to nutrients. Despite the heterogeneity in genetic mutations that lead to …
order to gain access to nutrients. Despite the heterogeneity in genetic mutations that lead to …
Targeting the RNA polymerase I transcription for cancer therapy comes of age
Transcription of the ribosomal RNA genes (rDNA) that encode the three largest ribosomal
RNAs (rRNA), is mediated by RNA Polymerase I (Pol I) and is a key regulatory step for …
RNAs (rRNA), is mediated by RNA Polymerase I (Pol I) and is a key regulatory step for …
[HTML][HTML] mTOR inhibitors in cancer therapy
The mammalian target of rapamycin, mTOR, plays key roles in cell growth and proliferation,
acting at the catalytic subunit of two protein kinase complexes: mTOR complexes 1 and 2 …
acting at the catalytic subunit of two protein kinase complexes: mTOR complexes 1 and 2 …
Targeting ribosome biogenesis in cancer: lessons learned and way forward
A Zisi, J Bartek, MS Lindström - Cancers, 2022 - mdpi.com
Simple Summary Cells need to produce ribosomes to sustain continuous proliferation and
expand in numbers, a feature that is even more prominent in uncontrollably proliferating …
expand in numbers, a feature that is even more prominent in uncontrollably proliferating …
First-in-human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study
Abstract RNA polymerase I (Pol I) transcription of ribosomal RNA genes (rDNA) is tightly
regulated downstream of oncogenic pathways, and its dysregulation is a common feature in …
regulated downstream of oncogenic pathways, and its dysregulation is a common feature in …